Pfizer hikes U.S. prices for more than 100 drugsStaff writer ▼ | January 9, 2016
Pfizer on January 1 raised U.S. prices for more than 100 of its drugs, some by as much as 20 percent, according to statistics compiled by Wolters Kluwer.
Pharma industry New year, new prices from the pharmaceutical giant
Those price increases were compiled by a unit of Wolters Kluwer Health and published in a research note by UBS Securities. UBS said Pfizer increased prices by 20 percent for anticonvulsant Dilantin, hormone therapy Menest, angina drug Nitrostat, Tykosyn for irregular heartbeat, and antibiotic Tygacil.
The analyst report said U.S. prices were raised on a total of 105 Pfizer drugs. No price reductions were reported. ■